Grants

PI Name PI Organization Title Grant Number Initiative Program Director
Chan, Andrew T

Massachusetts General Hospital
United States

 Precision Prevention Research Program 5R35CA253185-03 PAR-19-349 (R35 Clinical Trial Not Allowed) Asad Umar, D.V.M., Ph.D.
Chan, Andrew T

Massachusetts General Hospital
United States

 Precision Prevention Research Program 5R35CA253185-03 PAR-19-349 (R35 Clinical Trial Not Allowed) Asad Umar, D.V.M., Ph.D.
Chan, Andrew T

Massachusetts General Hospital
United States

 Precision Prevention Research Program 5R35CA253185-03 PAR-19-349 (R35 Clinical Trial Not Allowed) Asad Umar, D.V.M., Ph.D.
Chan, Andrew T

Massachusetts General Hospital
United States

 Precision Prevention Research Program 5R35CA253185-03 PAR-19-349 (R35 Clinical Trial Not Allowed) Asad Umar, D.V.M., Ph.D.
Chang, Su-Hsin

Washington University
United States

 Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective 5R01CA253475-03 Asad Umar, D.V.M., Ph.D.
Chung, Raymond T

Massachusetts General Hospital
United States

 Trial of Statins for Chemoprevention in Hepatocellular Carcinoma 5R01CA255621-02 Asad Umar, D.V.M., Ph.D.
El-Serag, Hashem B

Baylor College Of Medicine
United States

 Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome 1P01CA263025-01A1 Asad Umar, D.V.M., Ph.D.
Katona, Bryson William

University Of Pennsylvania
United States

 Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants 1R21CA267949-01A1 PAR-20-292 (R21 Clinical Trial Optional) Asad Umar, D.V.M., Ph.D.
Lipkin, Steven M

Weill Medical Coll Of Cornell Univ
United States

 (PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance 5R01CA231283-05 Asad Umar, D.V.M., Ph.D.
Malafa, Mokenge P

H. Lee Moffitt Cancer Ctr & Res Inst
United States

 Novel Therapy to Inhibit IPMN Progression 1R01CA263575-01A1 PAR-21-035 (R01 Clinical Trial Required) Asad Umar, D.V.M., Ph.D.